$176.95
4.052.34%
At close: -
$179.00
2.051.16%
After Hours: 4:05 PM EDT
Comments
Loading...
Quest Diagnostics Stock Guidance | NYSE:DGX | Benzinga
Quest Diagnostics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Quest Diagnostics (DGX)?
The most recent guidance for Quest Diagnostics (DGX) was reported on January 30, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $9.55 to $9.80, compared to the estimated EPS of $9.72. Additionally, Quest Diagnostics forecasted revenue between $10.70B and $10.85B for the quarter.
Browse guidance and forecast on all stocks.